1 asset in Oligodendroglioma
Therapeutic assets addressing Oligodendroglioma, rated under Floatz methodology v0.2 and sorted by current rating.
| Asset | Sponsor | Phase | Rating |
|---|---|---|---|
Niraparib Oligodendroglioma | University of Oklahoma | P2 | CCC (53) |
Therapeutic assets addressing Oligodendroglioma, rated under Floatz methodology v0.2 and sorted by current rating.
| Asset | Sponsor | Phase | Rating |
|---|---|---|---|
Niraparib Oligodendroglioma | University of Oklahoma | P2 | CCC (53) |